FindTrial
Sign In

Development of AXTEX-4D, a unique system to grow solid tumor outside body for clinically relevant studies and treatment protocol analysis

Assessment of Growth of primary cells form solid tumors on Axtex-4D, the Ex vivo tissueoid generator platform

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028608
Enrollment
1000
Registered
2020-10-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

None listed

Sponsors

Premas Biotech Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Absence of long term/chronic disease will be preferred 2. Sample cohort should be an heterogenous mixture of individuals from different demographic regions of the country with difference in ethnic and racial origin 3.Treatment naïve individuals

Exclusion criteria

Exclusion criteria: 1.Tissues from terminally ill patient. 2.Not require treatment-experienced or prior-treatment-failed â??salvageâ?? participants tumor. 3.Size

Design outcomes

Primary

MeasureTime frame
Development of tissueoid generation platform, AXTEX-4D, that shall aid in growing tumor tissues ex vivoTimepoint: Not Applicable—

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable—

Countries

India

Contacts

Public ContactAshok Jain

Premas Biotech Pvt Ltd

biswa.pratim@premasbiotech.com01244546600

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026